Agenesis of the Corpus Callosum

oPatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

Agenesis of the corpus callosum (ACC) is complete or partial absence of the structure that connects the two hemispheres of the brain - the corpus callosum, which is the largest fibre tract in the central nervous system. It can occur as an isolated condition or in combination with other cerebral abnormalities. These include:

Aicardi's syndrome is found in girls alone - see below under heading of that name.

ACC can also be associated with problems in other parts of the body, eg midline facial defects. There is a spectrum of disability ranging from subtle to severe depending on associated brain abnormalities. Intelligence may be normal with mild compromise of skills requiring matching of visual patterns. But children with the most severe brain malformations may have low intelligence quotient (IQ), seizures, hydrocephalus and spasticity.

It is one of the most frequent malformations in the brain with a reported incidence ranging between 0.5 and 70 in 10,000 births.[1]

NEW - log your activity

  • Notes Add notes to any clinical page and create a reflective diary
  • Track Automatically track and log every page you have viewed
  • Print Print and export a summary to use in your appraisal
Click to find out more »

Formation of the corpus callosum begins as early as 6 weeks' gestation, with the first fibres crossing the midline at 11 to 12 weeks' gestation. The basic shape is completed by 18 to 20 weeks' gestation.

As yet unknown factors cause disruption to development of the fetal brain between the 3rd and 12th week of pregnancy. Potential causes may include chromosome errors, inherited genetic factors, prenatal infections or injuries, prenatal toxic exposures, structural blockage by cysts or other brain abnormalities and metabolic disorders.[2]

There is a wide spectrum of clinical presentation, but those common to most children with callosal abnormalities include:[3]

  • Vision impairment.
  • Hypotonia.
  • Poor motor co-ordination.
  • Delays in motor milestones.
  • Low perception of pain.
  • Delayed toilet training.
  • Early feeding/chewing and swallowing difficulties.
  • Seizures.
  • Spasticity.
  • Gastro-oesophageal reflux.
  • Hearing impairments.
  • Abnormal head and facial features.
  • Learning difficulties.

Some children have cognitive disabilities (difficulty in complex problem solving) and social difficulties (missing subtle social cues), even when their IQ is normal. This has been found to be due to abnormal face processing and may lead to confusion with autistic spectrum disorders.

This is a rare genetic condition with probably only 300 to 500 cases worldwide. It is characterised by:[4]

  • Complete or partial absence of the corpus callosum.
  • Chorioretinal lacunae.
  • Severe seizures.

Nearly all children with Aicardi's syndrome have severe learning difficulties:

  • Most have no expressive language and remain totally dependent.
  • A few have some understanding of language, can walk with support or independently and are fairly responsive to the environment.

Also:

  • Self-harm and aggression towards people and objects have been reported and may be involuntary.
  • Disturbed sleep and waking in the night are common and possibly due to fitting. An electroencephalogram (EEG) may show the characteristic pattern of hypsarrhythmia - sometimes called West's syndrome.[5]
  • MRI scan or CT scan of head will help demonstrate the loss of neural tissue

The outcome of Aicardi's syndrome is severe, with a high early mortality, considerable morbidity and a generally poor developmental outcome.[6]

Structural brain abnormalities are diagnosed by MRI or CT scan, prenatal ultrasound, or prenatal MRI.

There are no specific treatments for agenesis of the corpus callosum (ACC) but most patients will require input from a multidisciplinary team. This may include neurologists, neuropsychologists, occupational therapists, physiotherapists, speech and language therapists, paediatricians, geneticists, specific schooling support and early intervention specialists.

Prognosis depends on the extent and severity of malformations.[7] It is not possible for the corpus callosum to regenerate or degenerate.

Although some individuals with callosal disorders have average intelligence and lead normal lives, neuropsychological testing reveals subtle differences in higher cortical function compared with individuals of the same age and education without agenesis of the corpus callosum (ACC).

Further reading & references

  • Aribandi M; Imaging in Agenesis of the Corpus Callosum: Multimedia, eMedicine, Oct 2009
  1. Agenesis of corpus callosum, Online Mendelian Inheritance in Man (OMIM)
  2. O'Driscoll MC, Black GC, Clayton-Smith J, et al; Identification of genomic loci contributing to agenesis of the corpus callosum. Am J Med Genet A. 2010 Sep;152A(9):2145-59.
  3. Bedeschi MF, Bonaglia MC, Grasso R, et al; Agenesis of the corpus callosum: clinical and genetic study in 63 young patients. Pediatr Neurol. 2006 Mar;34(3):186-93.
  4. Aicardi J, Chevrie JJ, Rousselie F; Spasma-in-flexion syndrome, callosal agenesis, chorioretinal abnormalities. Arch Fr Pediatr. 1969;26(10):1103-20.
  5. Fariello RG, Chun RW, Doro JM, et al; EEG recognition of Aicardi's syndrome. Arch Neurol. 1977 Sep;34(9):563-6.
  6. Aicardi J; Aicardi syndrome. Brain Dev. 2005 Apr;27(3):164-71.
  7. Schell-Apacik CC, Wagner K, Bihler M, et al; Agenesis and dysgenesis of the corpus callosum: clinical, genetic and Am J Med Genet A. 2008 Oct 1;146A(19):2501-11.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Hayley Willacy
Current Version:
Last Checked:
19/11/2010
Document ID:
1783 (v23)
© EMIS